[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10038 Introduced in House (IH)]
<DOC>
118th CONGRESS
2d Session
H. R. 10038
To direct the Secretary of Veterans Affairs to conduct a pilot program
on the provision of naloxone to veterans and their caregivers, and for
other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
October 25, 2024
Mr. D'Esposito (for himself, Mr. Trone, Mr. LaLota, Mr. Lawler, and Mr.
Langworthy) introduced the following bill; which was referred to the
Committee on Veterans' Affairs
_______________________________________________________________________
A BILL
To direct the Secretary of Veterans Affairs to conduct a pilot program
on the provision of naloxone to veterans and their caregivers, and for
other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. DEPARTMENT OF VETERANS AFFAIRS PILOT PROGRAM ON PROVISION OF
NALOXONE TO VETERANS AND THEIR CAREGIVERS.
(a) In General.--The Secretary of Veterans Affairs shall carry out
a two-year pilot program under which the Secretary shall make naloxone
available at pharmacies and medical facilities of the Department to any
veteran or registered caregiver of a veteran at no charge and without a
prescription.
(b) Provision of Information.--The Secretary shall ensure that any
veteran or registered caregiver who receives naloxone under the pilot
program also receives--
(1) information about addiction services, suicide
prevention services, mental health services, and other related
services provided by the Department of Veterans Affairs; and
(2) information about available resources for education on
the use and application of naloxone.
(c) Report.--Not later than 90 days after the completion of the
pilot program under this section, the Secretary shall submit to
Congress a report on the pilot program. Such report shall include each
of the following:
(1) The number of veterans and registered caregivers who
received naloxone under the pilot program.
(2) An assessment of the feasibility of expanding the pilot
program in order to provide naloxone to immediate family
members of veterans.
(3) An assessment of the feasibility or expanding the pilot
program to include non-Department medical providers through
which the Secretary furnishes hospital care, medical services,
and extended care services to veterans under section 1703 of
title 38, United States Code.
(4) An assessment of the effect of a requirement for a
consultation by an appropriate medical provider of the
Department when providing naloxone to any veteran or registered
caregiver for a second time, including whether such a
consultation requirement would be likely to reduce the number
of veterans and registered caregivers who request naloxone for
a second time.
(5) Any budgetary considerations associated with
continuing, expanding, or making permanent the pilot program.
(6) Any other recommendations of the Secretary with respect
to modifying or continuing the pilot program.
<all>